EUVIMEDEUVIMED entdecken
Crossref

Survival outcomes of eyelid lymphoma: a SEER database analysis

Kyle A Deistler, Edward J Wladis

Orbit · 2026

DOI: 10.1080/01676830.2026.2624005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Orbit, 2026. Verfasst von Kyle A Deistler und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Albany Medical Center, Albany, New York, USA. Hauptthemen laut MEDLINE: Eyelid Neoplasms, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Lymphoma, Large B-Cell, Diffuse. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate associations between treatment modality and survival in patients with eyelid lymphoma using the SEER national cancer registry, and to identify demographic predictors of prognosis.

Methods

Data from the Surveillance, Epidemiology, and End Results (SEER) database (2000–2021) were analyzed for patients with histologically confirmed eyelid lymphoma. Demographic, histologic, and treatment variables were assessed using Kaplan-Meier and Cox proportional hazards models for 5 year and overall survival respectively.

Results

Among 509 cases, extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT; 47.5%) was most common, followed by follicular lymphoma (19.6%) and diffuse large B-cell lymphoma (DLBCL; 12.0%). Radiation therapy was associated with improved survival in patients with MALT lymphoma (p < 0.05) but not in other subtypes. Chemotherapy was not independently associated with improved survival. Increased age at diagnosis and male gender were independent predictors of decreased survival (p < 0.05). Race, income, and marital status were not associated with altered five-year survival.

Conclusions

This population-based analysis demonstrates that survival in eyelid lymphoma varies by histologic subtype and is independently associated with age, sex, and radiation therapy use in MALT lymphoma. Findings should be interpreted in light of inherent limitations of registry data, including incomplete treatment and staging information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eyelid NeoplasmsLymphoma, B-Cell, Marginal ZoneLymphomaLymphoma, Large B-Cell, DiffuseHumansFemaleMaleSEER ProgramMiddle AgedAgedUnited StatesSurvival RateAged, 80 and overPrognosisAdultProportional Hazards ModelsKaplan-Meier EstimateLymphoma, Follicular

Stichwörter der Autor:innen

Eyelidchemotherapylymphomaprognosisradiation

Autor:innen und Institutionen

  • Department of Ophthalmology, Albany Medical Center, Albany, New York, USA.

Zitieren

APA

Deistler, K. A., & Wladis, E. J. (2026). Survival outcomes of eyelid lymphoma: a SEER database analysis. Orbit. https://doi.org/10.1080/01676830.2026.2624005

Vancouver

Deistler KA, Wladis EJ. Survival outcomes of eyelid lymphoma: a SEER database analysis. Orbit. 2026. doi:10.1080/01676830.2026.2624005

BibTeX
@article{Deistler2026,
  author = {Deistler, Kyle A and Wladis, Edward J},
  title = {Survival outcomes of eyelid lymphoma: a SEER database analysis},
  journal = {Orbit},
  year = {2026},
  doi = {10.1080/01676830.2026.2624005}
}
Kostenlos starten →